CLINICAL SCIENCES Delay in Diagnosis and Other Factors Impacting Morbidity Sarju S. Patel, MD, MPH, MSc; Nehali V. Saraiya, MD; Howard H. Tessler, MD; Debra A. Goldstein, MD Importance: The reported outcomes of ocular myco- cobacterial infection. Chest imaging was consistent with bacterial infection are commonly unfavorable. This study granulomatous disease in 46.7%. Average delay from ocu- is among the first to elucidate factors associated with poor lar disease onset to uveitis service referral was 755.3 days. outcomes, as well as highlight the continued controver- Posterior uveitis and non-Hispanic white race were as- sies in therapy, particularly the role of oral corticoste- sociated with increased delay. A relapsing course was ob- roids. served in posterior uveitis (odds ratio [OR], 20.0; 95% CI, 1.39-287; P=.03) and those treated with systemic ste- Objective: To describe presentations and outcomes of roids for eye disease (OR, 10.1; 95% CI,1.60-64.0; P=.01). mycobacterial ocular disease in the Midwestern United Disease control was achieved in 81%, although 38.5% had States. profound visual loss, associated with age older than 50 years and delay in diagnosis. Patients diagnosed after 500 Design: Retrospective case series. days from initial ocular symptoms were more likely to lose vision (OR, 20.0; 95%
JAMA Ophthalmology – American Medical Association
Published: Jun 1, 2013
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera